Mondelez International Inc (MDLZ) Pops 2.94% for January 29

Equities Staff |

One of the S&P 500’s big winners for Friday January 29 was Mondelez International Inc (MDLZ) as the company’s stock climbed 2.94% to $42.77 on volume of 6.13 million shares.

The stock opened at $42.08 and saw an intraday low of $41.83 and an intraday high of $42.86. All told, the day saw a per-share gain of $1.22. The stock’s average daily volume of 9.14 million and 1.59 billion shares outstanding. Mondelez International Inc now has a 50-day SMA is $43.20 and 200-day SMA is $42.25, and it has a 52-week high of $48.58 and a 52-week low of $33.97.

Mondelez International Inc manufactures confectionery products. It produces packaged food products, including biscuits, confectionery, beverages, cheese, convenient meals and various packaged grocery products.

Based out of Deerfield, IL, Mondelez International Inc has 104,000 employees and, after today’s trading, reached a market cap of $67.97 billion. The stock’s P/E Ratio is 8. Its P/S ratio is 2.96, P/B ratio is 2.28, and P/FCF ratio is 21.5.

For a complete fundamental analysis analysis of Mondelez International Inc, check out’s Stock Valuation Analysis report for MDLZ. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…